[Neurological manifestations of HIV-infection in the era of highly active antiretroviral therapy (HAART)]
- PMID: 16217698
- DOI: 10.1055/s-2004-830283
[Neurological manifestations of HIV-infection in the era of highly active antiretroviral therapy (HAART)]
Abstract
After the introduction of highly active antiretroviral therapy (HAART) in 1996 the neurological manifestations of human immunodeficiency virus (HIV-1)-infection did not decline in incidence and prevalence like the other complications of immunodeficiency; in contrast, due to the longer survival times of HAART treated HIV-1-positive individuals, prevalence of virus associated neurological disease increased during the last years, as international studies underline. Therefore, clinicians and HIV-therapists should be able to diagnose HIV-1-associated neurological disease even in early stages. This article describes symptoms and signs, neuro-imaging and cerebrospinal fluid findings as well as therapy options in primary HIV-1-associated neurological disease like encephalo- and myelopathy and polyneuropathy. Furthermore, those opportunistic infections, caused by bacteria, viruses other than HIV and parasites emerging with manifest immunodeficiency and remaining to be relevant in the HAART era are presented from diagnostic, differential-diagnostic and therapeutic points of view. An extra paragraph describes the interaction of HAART with neurological/psychiatric standard therapies.
Similar articles
-
Highly active antiretroviral therapy access and neurological complications of human immunodeficiency virus infection: impact versus resources in Brazil.J Neurovirol. 2005;11 Suppl 3:11-5. doi: 10.1080/13550280500511360. J Neurovirol. 2005. PMID: 16540448 Review.
-
The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.J Neurovirol. 2002 Dec;8 Suppl 2:115-21. doi: 10.1080/13550280290101094. J Neurovirol. 2002. PMID: 12491162 Review.
-
[Neurological complications of HIV infection. Review: new diagnostic, therapeutic and prognostic aspects].Schweiz Med Wochenschr. 2000 Apr 1;130(13):457-70. Schweiz Med Wochenschr. 2000. PMID: 10812641 Review. German.
-
[Neurologic complications of HIV infection in the HAART era. Rapid and efficient diagnosis].MMW Fortschr Med. 2003 Apr 28;145 Spec No 1:66-9. MMW Fortschr Med. 2003. PMID: 15011596 German.
-
[Neuro-AIDS in the cART era].Fortschr Neurol Psychiatr. 2012 Aug;80(8):450-7. doi: 10.1055/s-0032-1313191. Epub 2012 Aug 15. Fortschr Neurol Psychiatr. 2012. PMID: 22895840 Review. German.
Cited by
-
[Neurological complications of HIV infection].Nervenarzt. 2008 Dec;79(12):1449-62; 1463. doi: 10.1007/s00115-008-2588-x. Nervenarzt. 2008. PMID: 19023553 German.
-
[Infections of the central nervous system in the immuno-compromised].Nervenarzt. 2008 Sep;79 Suppl 2:93-108; quiz 109. doi: 10.1007/s00115-008-2462-x. Nervenarzt. 2008. PMID: 18679642 Review. German.
-
Dopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1-infected brains.J Neurovirol. 2006 Apr;12(2):140-5. doi: 10.1080/13550280600724319. J Neurovirol. 2006. PMID: 16798675 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical